Themis Medicare (BOM:530199) Cyclically Adjusted PS Ratio: (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530199 Themis Medicare Ltd BOM:530199
69 GF Score
Price ₹104.70
GF Value ₹148.81
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Themis Medicare Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Themis Medicare  (BOM:530199) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Themis Medicare Cyclically Adjusted PS Ratio Related Terms


Themis Medicare Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Themis Medicare's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Themis Medicare Cyclically Adjusted PS Ratio Chart

Themis Medicare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.94 3.42 6.09 3.90 1.71

Themis Medicare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.40 3.49 2.61 1.71 0.00

BOM:530199 vs ZTS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Themis Medicare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Themis Medicare Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Themis Medicare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Themis Medicare's Cyclically Adjusted PS Ratio falls into.


BOM:530199
69GF Score
Themis Medicare Ltd BOM:530199
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Themis Medicare Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Themis Medicare's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Themis Medicare's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=9.434/167.3573*167.3573
=9.434

Current CPI (Jun. 2026) = 167.3573.

Themis Medicare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 7.240 105.961 11.435
201609 6.087 105.961 9.614
201612 5.874 105.196 9.345
201703 5.408 105.196 8.604
201709 6.695 109.021 10.277
201712 5.385 109.404 8.238
201803 5.603 109.786 8.541
201806 5.400 111.317 8.119
201809 5.418 115.142 7.875
201812 5.354 115.142 7.782
201903 4.020 118.202 5.692
201906 5.593 120.880 7.743
201909 5.487 123.175 7.455
201912 5.857 126.235 7.765
202003 4.885 124.705 6.556
202006 5.279 127.000 6.957
202009 5.972 130.118 7.681
202012 7.129 130.889 9.115
202103 6.577 131.771 8.353
202106 12.217 134.084 15.249
202109 11.644 135.847 14.345
202112 10.294 138.161 12.469
202203 8.308 138.822 10.016
202206 10.245 142.347 12.045
202209 9.873 144.661 11.422
202212 9.604 145.763 11.027
202303 7.624 146.865 8.688
202306 10.466 150.280 11.655
202309 11.386 151.492 12.578
202312 8.959 152.924 9.805
202403 10.048 153.035 10.988
202406 13.353 155.789 14.345
202409 12.689 157.882 13.451
202412 10.838 158.323 11.456
202503 7.790 157.552 8.275
202506 10.568 159.755 11.071
202509 8.413 162.289 8.676
202512 9.733 163.281 9.976
202603 8.268 164.272 8.423
202606 9.434 167.357 9.434

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Themis Medicare (BOM:530199) Overvalued in 2026?

Based on GuruFocus' analysis, Themis Medicare stock appears to be undervalued. The current stock price of ₹104.70 is trading 29.6% below its estimated GF Value™ of ₹148.81. GuruFocus considers Themis Medicare to be Modestly Undervalued.

Key valuation signals for BOM:530199:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹148.81 vs. price of ₹104.70 (29.6% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the BOM:530199 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Themis Medicare Business Description

Other Exchanges THEMISMED:India
Address Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
69GF Score

Get the complete analysis for BOM:530199

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹104.70
Price
₹148.81
GF Value